A Study of XW003 in Obese Participants With Obstructive Sleep Apnea Receiving Positive Airway Pressure Therapy
The aim of the study is to assess the efficacy and safety of XW003 injections in obese participants with OSA receiving PAP
Body mass index (BMI) ≥ 28.0 kg/m2; [+3]
History of endocrine disorders which have significant impact on body weight; [+9]